Could reduce a 25 percent increase in the detection of hypertension in 19 developing countries, cardiovascular diseases (CVD) events and deaths that occur each year, up to 3 percent in these countries, a new study has suggested. The study by researchers at Harvard Medical School found that about 900 million people in developing countries have high blood pressure, but only a third are aware of their disease.
In addition, only 100 million of these people are treated, while only 5 percent of the total can be controlled.
In this context, this study designed to evaluate the cost-effectiveness of an intervention in order to demonstrate increased from 25 percent in developing countries with a screening instrument in a laboratory, not to people with a treat blood pressure over 140 mmHg systolic and CVD risk more than 20 percent.
The study found that the investigation would be 25 percent of the population in an increase of over 10 percent lead in the rate of appropriate treatment of hypertension in patients at high risk.
The operation would lead to about 3.1 percent fewer cardiovascular events and death. In addition, increasing cost-benefit ratio of screening programs have been clearly observed under a times the GDP per capita in 19 developing countries.
"Strategies can increase the detection of high blood pressure can lead to a significant reduction in deaths due to CVD, at a cost that is acceptable according to WHO recommendations," said Dr. Thomas Gaziano, associate professor of the Faculty of Medicine at Harvard University.
The preliminary data was presented at the World Congress of Cardiology.
In addition, only 100 million of these people are treated, while only 5 percent of the total can be controlled.
In this context, this study designed to evaluate the cost-effectiveness of an intervention in order to demonstrate increased from 25 percent in developing countries with a screening instrument in a laboratory, not to people with a treat blood pressure over 140 mmHg systolic and CVD risk more than 20 percent.
The study found that the investigation would be 25 percent of the population in an increase of over 10 percent lead in the rate of appropriate treatment of hypertension in patients at high risk.
The operation would lead to about 3.1 percent fewer cardiovascular events and death. In addition, increasing cost-benefit ratio of screening programs have been clearly observed under a times the GDP per capita in 19 developing countries.
"Strategies can increase the detection of high blood pressure can lead to a significant reduction in deaths due to CVD, at a cost that is acceptable according to WHO recommendations," said Dr. Thomas Gaziano, associate professor of the Faculty of Medicine at Harvard University.
The preliminary data was presented at the World Congress of Cardiology.
No comments:
Post a Comment